Skip to main content

Animations

MJFF Publications

1951 - 1960 of 8571 Results
Title
Year
  • Year
  • 2021
  • 2016
  • 2020
  • 2019
  • 2016
  • 2021
  • 2018
  • 2020
  • 2024
  • 2018
  • Summary Details
    OPEN
    Title: Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202013257
    Citation Count: 128
  • Summary Details
    RESTRICTED
    Title: Detection of Proteolytic Signatures for Parkinson's Disease
    Journal Name: Future Neurology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/fnl.16.3
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Netrin‐1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson’s disease features
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.2020105537
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Epidural Spinal Cord Stimulation Improves Motor Function in Rats With Chemically Induced Parkinsonism
    Journal Name: Neurorehabilitation and Neural Repair
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/1545968319876891
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/ana.24781
    Citation Count: 246
  • Summary Details
    OPEN
    Title: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy
    Journal Name: ACS Pharmacology & Translational Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0235-y
    Citation Count: 106
  • Summary Details
    RESTRICTED
    Title: Carepartner Communication on Parkinson Disease Psychosis (4116)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Detecting the symptoms of Parkinson’s disease with non-standard video
    Journal Name: Journal of NeuroEngineering and Rehabilitation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12984-024-01362-5
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.10.018
    Best OA location URL:
    Citation Count: 32
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.